Renown Welcomes the First Transplant Nephrologist to Region & Announces Renown Transplant Institute
October 03, 2024 17:26 ET
|
Renown Health
Reno, NEV., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Renown Health is pleased to announce the appointment of Narisorn Atsava-Svate, MD, a distinguished transplant nephrologist. With over 18 years of...
Hair Transplant Market Trends and Opportunities to 2030 by Age Group, Hair Loss Type, Service Provider, and Country with In-Depth Analysis of the Competitive Landscape
September 18, 2024 04:08 ET
|
Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Global Hair Transplant Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Age Group, Hair Loss Type, Service Provider, Region, By...
Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
August 14, 2024 17:21 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
July 02, 2024 16:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
Global Flow Cytometry Industry Outlook Report, 2024-2032: Market Dynamics, Technology Insights, Patent Analysis (2014-2024), and Profiles of Leading Players Including BD and Danaher
June 19, 2024 04:10 ET
|
Research and Markets
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "Global Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits),...
Translational Regenerative Medicine Market Set to Surpass $77 Billion in 2024
June 06, 2024 04:10 ET
|
Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Translational Regenerative Medicine Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.Overall world revenue for the...
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
June 03, 2024 16:01 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
May 09, 2024 07:30 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
May 07, 2024 07:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
Global Bionic Devices Industry Research, 2023-2024 & 2030: Addressing Diverse Healthcare Needs Worldwide to Sustain Growth and Fuel Develoments
April 25, 2024 05:29 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Global Bionic Devices Market, By Product, By Fixation, By Technology, By End User, Country Wise Market Analysis, Key Company Profiles, Trends and...